View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/CDC | RIN: 0920-AA85 | Publication ID: Fall 2024 |
| Title: Import Regulations for Infectious Biological Agents, Infectious Substances, Vectors, and Nucleic Acids Capable of Producing Infectious Viruses | |
|
Abstract:
This proposed rulemaking will clarify import permit requirements for those who intend to apply for an import permit. The rulemaking will improve HHS/CDC’s ability to prevent the introduction, transmission, or spread of communicable disease into the United States. |
|
| Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
| Major: No | Unfunded Mandates: No |
| CFR Citation: 42 CFR 71.54 | |
| Legal Authority: 42 U.S.C. 264 | |
|
Legal Deadline:
None |
||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Federalism: No | |
| Included in the Regulatory Plan: No | |
| International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest. | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Daniel A Singer Acting Director, Division of Regulatory Science and Compliance Department of Health and Human Services Centers for Disease Control and Prevention 1600 Clifton Road NE, H21-4, Atlanta, GA 30329 Phone:404 718-2000 Email: lrsat@cdc.gov |
|
An official website of the United States government



